Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation
John Nixon, Paul Newbold, Tomas Mustelin, Gary P Anderson, Roland Kolbeck
Pharmacology & Therapeutics | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2017
Related Projects (1)
Editing assistance was provided by Elizabeth Strickland, PhD, of JK Associates, Conshohocken, PA, and Michael A. Nissen, ELS, of AstraZeneca, Gaithersburg, MD. This assistance was funded by AstraZeneca, Gaithersburg, MD, USA.